Pfizer UK removes sales incentives for anti-infectives

  28 September 2019

Pfizer UK has changed how it incentivises its anti-infectives field-force under the drug giant’s commitment to the fight against antimicrobial resistance (AMR).

All sales have been ‘de-linked’ from its anti-infectives (AI) field-force incentives, with the focus now on measuring management-based objectives (MBOs) centering on generating access to medicines and promoting the appropriate use of antibiotics.

Further reading: PharmaTimes
Author(s): Pharmatimes
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed